History

CYPRIO was founded end of 2017 after 10 years of research, development and collaboration between the Paris School of Industrial Physics and Chemistry, ESPCI Paris (“Ecole Supérieure de Physique et Chimie Industrielles de la Ville de Paris”) and industrial partners with strong expertise in the fields of physiochemistry, 3D cell culture, liver biology, high throughput screening and tissue engineering.

ESPCI Paris is member of the PSL University and has more than 500 researchers and 400 students.  It is also an international center for research in physics, chemistry and biology. Six of its scientists have won Nobel Prizes in physics or chemistry including Marie Curie and Pierre-Gilles de Gennes.

Over the past 5 years, we have developed products and services in parallel in a fast-changing market.  There is no doubt there is a crucial need for new predictive cellular models. There is still the market acceptance to come by but our perspectives is the following:

1. There is a need for more complex solutions closer and closer to organs:  new molecules or treatments request robust, reproducible testing.  Predictivity issues have arisen as many drugs failed in clinical trials.

2. There is no turning back to animal experimentation: EU already banned animal testing for cosmetics and this will be extended in next years in other testing fields everywhere.

3. There is a request to go faster and further in development and therapy, especially in terms of precision and personalized medicine:  quickly find the right treatment may be critical not only in oncology or neurology.